Abstract
Background
The metabolic syndrome (MetS) is characterized by a cluster of metabolic factors, including insulin resistance and type-2 diabetes, abdominal obesity, dyslipidemia, hypertension and microalbuminuria. Impaired glucocorticoid receptor (GR) activity also plays an important role in the etiology of MetS. The objective of our study is to evaluate the effects of GR gene polymorphisms (BclI, N363S, TthIII1 and ER22/23EK) in Turkish patients with MetS.
Materials and methods
Seventy subjects with MetS and 185 healthy controls were enrolled in the study. PCR–RFLP analysis was used for genotyping. Results for each polymorphism have been verified by allele-specific oligonucleotide analysis.
Results
BclI GG genotype was significantly associated with an increased risk of MetS (p = 0.02). Also, only in women, the G allele carriers were significantly associated with higher C-peptide. T allele carriers of TthIII1 polymorphism were significantly associated with higher C-peptide, triglyceride, insulin and C-reactive protein (CRP, p value 0.048, 0.022, 0.005 and 0.022, respectively), and lower fasting blood glucose (FBG, p = 0.02). The combined carriers of BclI polymorphism G allele and TthIII1 polymorphism T allele were significantly associated with higher diastolic blood pressure in all patients, and lower FBG and postprandial blood glucose in only men. All the ER22/23EK polymorphisms coexisted with polymorphic variant of TthIII1 (p = 0.0058).
Conclusion
The presence of homozygote polymorphic variant of BclI might be good predictive markers for the disease susceptibility. The BclI and the TthIII1 polymorphism are associated with sex-specific clinical parameters. Our findings also suggest that the combination of BclI and TthIII1 polymorphisms may play a protective role in blood glucose.


Similar content being viewed by others
References
Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539–553
Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C; National Heart, Lung, and Blood Institute; American Heart Association (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24(2):e13–e18
Rosmond R (2002) The glucocorticoid receptor gene and its association to metabolic syndrome. Obes Res 10:1078–1086
van Rossum EF, Koper JW, Huizenga NA, Uitterlinden AG, Janssen JA, Brinkmann AO, Grobbee DE, de Jong FH, van Duyn CM, Pols HA, Lamberts SW (2002) A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 51:3128–3134
van Rossum EF, Koper JW, van den Beld AW, Uitterlinden AG, Arp P, Ester W, Janssen JA, Brinkmann AO, de Jong FH, Grobbee DE, Pols HA, Lamberts SW (2003) Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo, and body mass index. Clin Endocrinol (Oxf) 59(5):585–592
Manenschijn L, van den Akker EL, Lamberts SW, van Rossum EF (2009) Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann N Y Acad Sci 1179:179–198
Buemann B, Vohl MC, Chagnon M, Chagnon YC, Gagnon J, Pérusse L, Dionne F, Després JP, Tremblay A, Nadeau A, Bouchard C (1997) Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res 5:186–192
Weaver JU, Hitman GA, Kopelman PG (1992) An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyper insulinaemia in obese women. J Mol Endocrinol 9:295–300
Rosmond R, Chagnon YC, Holm G, Chagnon M, Pérusse L, Lindell K, Carlsson B, Bouchard C, Björntorp P (2000) A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic–pituitary–adrenal axis. Obes Res 8:211–218
Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH, Lamberts SW (1998) A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 83:144–151
Feng J, Zheng J, Bennett WP, Heston LL, Jones IR, Craddock N, Sommer SS (2000) Five missense variants in the amino-terminal domain of the glucocorticoid receptor: no association with puerperal psychosis or schizophrenia. Am J Med Genet 96:412–417
Lin RC, Wang XL, Dalziel B, Caterson ID, Morris BJ (2003) Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obes Res 11(6):802–808
Ikeda Y, Suehiro T, Tsuzura S, Shiinoki T, Kaneda T, Kumon Y, Hashimoto K (2001) A polymorphism in the promoter region of the glucocorticoid receptor gene is associated with its transcriptional activity. Endocr J 48:723–726
Lei SF, Deng FY, Liu XH, Huang QR, Qin Y, Zhou Q, Jiang DK, Li YM, Mo XY, Liu MY, Chen XD, Wu XS, Shen H, Dvornyk V, Zhao L, Recker RR, Deng HW (2003) Polymorphisms of four bone mineral density candidate genes in Chinese populations and comparison with other populations of different ethnicity. J Bone Miner Metab 21:34–42
Yan YX, Dong J, Zhang J, Liu F, Wang W, Zhang L, He Y (2014) Polymorphisms in NR3C1 gene associated with risk of metabolic syndrome in a Chinese population. Endocrine 47(3):740–748
van Rossum EF, Feelders RA, van den Beld AW, Uitterlinden AG, Janssen JA, Ester W, Brinkmann AO, Grobbee DE, de Jong FH, Pols HA, Koper JW, Lamberts SW (2004) Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men. Am J Med 117:158–162
Rosmond R, Chagnon YC, Chagnon M, Pérusse L, Bouchard C, Björntorp P (2000) A polymorphism of the 5′-flanking region of the glucocorticoid receptor gene locus is associated with basal cortisol secretion in men. Metabolism 49(9):1197–1199
van Rossum EF, Roks PH, de Jong FH, Brinkmann AO, Pols HA, Koper JW, Lamberts SW (2004) Characterization of a promoter polymorphism in the glucocorticoid receptor gene and its relationship to three other polymorphisms. Clin Endocrinol 61(5): 573–581 (9)
Loparev VN, Cartas MA, Monken CE, Velpandi A, Srinivasan A (1991) An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents, J Virol Methods 34(1):105–112
Bachmann AW, Sedgley TL, Jackson RV, Gibson JN, Young RM, Torpy DJ (2005) Glucocorticoid receptor polymorphisms and post-traumatic stress disorder. Psychoneuroendocrinology 30(3):297–306
Tissing WJ, Meijerink JP, den Boer ML, Brinkhof B, van Rossum EF, van Wering ER, Koper JW, Sonneveld P, Pieters R (2005) Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia. Clin Cancer Res 11:6050–6056
Tamashiro KL, Sakai RR, Shively CA, Karatsoreos IN, Reagan LP (2011) Chronic stress, metabolism, and metabolic syndrome. Stress. 14(5):468–474
Zhou J, Cidlowski JA (2005) The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70(5–7):407–417
Moreira RP, Gomes LG, Mendonca BB, Bachega TA (2012) Impact of glucocorticoid receptor gene polymorphisms on the metabolic profile of adult patients with the classical form of 21-hydroxylase deficiency. PLoS One 7:e44893
Duan ZX, Gu W, Du DY, Hu P, Jiang DP, Zhu PF, Wang ZG, Jiang JX (2009) Distributions of glucocorticoid receptor gene polymorphisms in a Chinese Han population and associations with outcome after major trauma. Injury 40(5):479–483
Koyano S, Saito Y, Sai K, Kurose K, Ozawa S, Nakajima T, Matsumoto K, Saito H, Shirao K, Yoshida T, Minami H, Ohtsu A, Saijo N, Sawada J (2005) Novel genetic polymorphisms in the NR3C1 gene in a Japanese population. Drug Metab Pharmacokinet 20:79–84
Bray PJ, Cotton RG (2003) Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum Mutat 21:557–568
Yan YX, Dong J, Wu LJ, Shao S, Zhang J, Zhang L, Wang W, He Y, Liu YQ (2013) Associations between polymorphisms in the glucocorticoid-receptor gene and cardiovascular risk factors in a Chinese population. J Epidemiol 23(5):389–395
Koeijvoets KC, van der Net JB, van Rossum EF, Steyerberg EW, Defesche JC, Kastelein JJ, Lamberts SW, Sijbrands EJ (2008) Two common haplotypes of the glucocorticoid receptor gene are associated with increased susceptibility to cardiovascular disease in men with familial hypercholesterolemia. J Clin Endocrinol Metab 93(12):4902–4908
Kumsta R, Entringer S, Koper JW, van Rossum EF, Hellhammer DH, Wüst S (2007) Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus–pituitary–adrenal axis responses to psychosocial stress. Biol Psychiatry 62(8):863–869
Melcescu E, Griswold M, Xiang L, Belk S, Montgomery D, Bray M, Del Ben KS, Uwaifo GI, Marshall GD, Koch CA (2012) Prevalence and cardiometabolic associations of the glucocorticoid receptor gene polymorphisms N363S and BclI in obese and non-obese black and white Mississippians. Hormones (Athens) 11(2):166–177
Manenschijn L, Scherzer R, Koper JW, Danoff A, van Rossum EF, Grunfeld C (2014) Association of glucocorticoid receptor haplotypes with body composition and metabolic parameters in HIV-infected patients from the FRAM study. Pharmacogenet Genomics 24(3):156–161
Mahajan A, Jaiswal A, Tabassum R, Podder A, Ghosh S, Madhu SV, Mathur SK, Tandon N, Bharadwaj D (2012) Elevated levels of C-reactive protein as a risk factor for metabolic syndrome in Indians. Atherosclerosis 220:275–281
Lee K, Song YM, Sung J (2013) Genetic and environmental associations between C-reactive protein and components of the metabolic syndrome. Metab Syndr Relat Disord 11(2):136–142
Van Rossum EF, Voorhoeve PG, te Velde SJ, Koper JW, Delemarre-van de Waal HA, Kemper HC, Lamberts SW (2004) The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J Clin Endocrinol Metab 89(8):4004–4009
Acknowledgments
The authors appreciate Dr. Can Erzik for his critical revision of the manuscript. This work was partly supported by a grant (104S272, SBAG-K-60 to SÇ) from the Scientific and Technological Research Council of Turkey (TUBITAK) and grants (SAG-C-DRP-101011-0286 to AO) from the Research Foundation of Marmara University (BAPKO).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no conflicts of interest.
Ethical approval
All the research has been performed according to the Ethical Standards involving human participants.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Z. Kaya and S. Caglayan contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kaya, Z., Caglayan, S., Akkiprik, M. et al. Impact of glucocorticoid receptor gene (NR3C1) polymorphisms in Turkish patients with metabolic syndrome. J Endocrinol Invest 39, 557–566 (2016). https://doi.org/10.1007/s40618-015-0409-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-015-0409-1